SCM
EOLS icon

Stonepine Capital Management’s Evolus EOLS Stock Holding History

Stonepine Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.23M Buy
1,759,091
+127,503
+8% +$618K 2.9% 6
2025
Q4 		$10.9M Buy
1,631,588
+95,197
+6% +$645K 7.92% 3
2025
Q3 		$9.43M Buy
1,536,391
+619,891
+68% +$4.83M 7.67% 3
2025
Q2 		$8.44M Sell
916,500
-218,074
-19% -$2.23M 8.28% 2
2025
Q1 		$13.6M Sell
1,134,574
-130,077
-10% -$1.7M 13.28% 2
2024
Q4 		$14M Sell
1,264,651
-105,170
-8% -$1.48M 11.27% 2
2024
Q3 		$22.2M Sell
1,369,821
-287,790
-17% -$4.02M 14.02% 2
2024
Q2 		$18M Sell
1,657,611
-1,016,745
-38% -$12.5M 16.41% 3
2024
Q1 		$37.4M Sell
2,674,356
-2,658,648
-50% -$34.6M 29.7% 1
2023
Q4 		$56.2M Buy
5,333,004
+154,000
+3% +$1.38M 24.29% 1
2023
Q3 		$47.3M Buy
5,179,004
+672,807
+15% +$6.03M 15.72% 2
2023
Q2 		$32.8M Buy
4,506,197
+3,927,402
+679% +$33.9M 11.82% 2
2023
Q1 		$4.9M Sell
578,795
-255,637
-31% -$2.31M 1.64% 14
2022
Q4 		$6.27M Buy
834,432
+634,432
+317% +$4.91M 2.64% 10
2022
Q3 		$1.61M Buy
+200,000
New +$2.12M 0.72% 18
2022
Q2 		– Sell
-586,224
Closed -$6.58M – 28
2022
Q1 		$6.58M Sell
586,224
-1,276,872
-69% -$10.9M 2.73% 15
2021
Q4 		$12.1M Buy
1,863,096
+1,563,096
+521% +$10.7M 5.57% 6
2021
Q3 		$2.29M Buy
+300,000
New +$3.1M 1.04% 18
2020
Q2 		– Sell
-822,960
Closed -$3.42M – 17
2020
Q1 		$3.42M Buy
822,960
+428,070
+108% +$3.63M 3.61% 12
2019
Q4 		$4.81M Buy
+394,890
New +$5.57M 3.35% 10
2018
Q2 		– Sell
-59,229
Closed -$535K – 26
2018
Q1 		$535K Buy
+59,229
New +$678K 0.29% 26

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stonepine Capital Management's EOLS Position: Q1 2026 in Review

Stonepine Capital Management increased its Evolus (EOLS) stake by 7.8% in Q1 2026, buying an estimated $618K and bringing the position to 1,759,091 shares worth $7.23M. The position accounts for 2.9% of the portfolio, ranked #6.

Stonepine Capital Management first reported a position in EOLS in Q1 2018 and has held it in 21 quarters since. The position peaked at $56.2M in Q4 2023. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Stonepine Capital Management held 1,759,091 shares of Evolus worth $7.23M as of Q1 2026.
  • Stonepine Capital Management bought 127,503 Evolus shares in Q1 2026, an estimated $618K.
  • Evolus made up 2.9% of Stonepine Capital Management's portfolio in Q1 2026, its #6 holding.
  • Stonepine Capital Management first reported a position in Evolus in Q1 2018 and has held it in 21 quarters since.
  • Stonepine Capital Management's Evolus position peaked at $56.2M in Q4 2023.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.